• The Susan F. Smith Center for Women's Cancers is a leader in patient-centered care. Patients are active members in their care and play a central role in all decision-making. Our center is committed to ensuring that all patients receive the medical treatment, information, and support they need. From providing support groups, counseling and social work, to nutrition consultations and integrative therapies, we are committed to helping ease the burden of cancer for our patients and their families.

  • Physicians at the Susan F. Smith Center for Women's Cancers provide insight into the latest research and treatment options for breast and gynecologic cancers and cancer genetics, risk, and prevention.

    Ian Krop, MD, PhD

    View the Slideshare presentation, "New Research in Treating HER2-Positive Breast Cancer," by Ian Krop, MD, PhD, director of clinical research in the Breast Oncology Program at Dana-Farber's Susan F. Smith Center for Women's Cancers. In the presentation, Dr. Krop discusses new advances in treating this disease, as well as new research in drug resistance.

    Erica Mayer, MD, H

    View the Slideshare presentation, "New Research in Treating ER-Positive Breast Cancer,” by Erica Mayer, MD, MPH, medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber. In the presentation, Dr. Mayer discusses the new advances in research and treatment for ER-positive breast cancer, including progress in handling drug resistance in the disease.

    Eric Winer, MD

    View the Slideshare presentation, "The Latest Treatments and Clinical Trials for HER2+ Metastatic Breast Cancer," by Eric Winer, MD, director of the Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber. In the presentation, Dr. Winer discusses the latest treatments and research around HER2+ breast cancers.

    View the Slideshare presentation, "The Latest Treatments and Clinical Trials for ER+ and Triple-Negative Breast Cancer," by Nancy Lin, MD, medical oncologist at the Susan F. Smith Center for Women’s Cancers at Dana-Farber. In the presentation, Dr. Lin discusses the latest treatments and research for ER+ and triple-negative breast cancers.

    The Truth About BRCA Testing and Genetic Risk
    In this archived video webchat, Huma Q. Rana, MD, clinical director of the Center for Cancer Genetics and Prevention at Dana-Farber, answers questions about genetic testing, BRCA, cancer genetics, and more.

     


    The Latest in Breast Cancer Treatment and Research
    In this archived video webchat, Eric Winer, MD, director of the Breast Oncology Program at the Susan F. Smith Center for Women's Cancers, answers questions about new research on breast cancer and treatment recommendations.

     


    Role of obesity and exercise in women's cancers
    Nancy Lin, MD, a breast oncologist in the Susan F. Smith Center for Women's Cancers at Dana-Farber, shares new data and research studies linking a healthy lifestyle to better treatment outcomes.

     


    Role of diet in women’s cancers
    Wendy Chen, MD, MPH, a breast oncologist in the Susan F. Smith Center for Women's Cancers at Dana-Farber, shares new data and research studies linking a healthy lifestyle to better treatment outcomes.

     


    What is DCIS?
    Learn more about DCIS, including treatment options, from Dr. Eric Winer, director of the Breast Oncology Program.

     


    View the Slideshare presentation, "Breast Cancer Genomics and Precision Medicine," by Nikhil Wagle, MD, medical oncologist in the Susan F. Smith Center for Women's Cancers at Dana-Farber, as he discusses the latest research in breast cancer genomics.

    View the Slideshare presentation, "Integrative Therapies for Breast Cancer Patients," by David Rosenthal, MD, of Dana-Farber's Zakim Center for Integrative Therapies, in which he discusses various mind-body exercises that can help breast cancer patients cope with treatment and side effects.

    Drs. Harold Burstein and Erica Mayer, medical oncologists in the Breast Oncology Program, recently answered patient questions through CancerConnect, Dana-Farber's online support community. Find answers to questions pertaining to breast cancer diagnosis and treatment.

    Dr. Ursula Matulonis, medical director of the Gynecologic Oncology Program, recently answered questions about uterine, ovarian, and cervical cancer through CancerConnect, Dana-Farber's online support community. Find answers to questions pertaining to the diagnosis and treatment of these gynecologic cancers.

    If you have questions about genetic testing or about cancer risk and its implications for you and your family, the Dana-Farber cancer genetics team is available to answer your questions.

    Submit your question through the Ask the Cancer Genetics Team Form.

    Review recent question topics: